Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.53 |
| ▸ | FABP4 | P15090 | 1/20 | 0.53 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.53 |
| ▸ | CDC25B | P30305 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.41 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | MYC | P01106 | 2/20 | 0.40 |
| ▸ | MAX | P61244 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16623900 | 0.88 | FABP3 (0.56) | FABP3FABP4FABP5CDC25BMEN1 | |
| SCHEMBL29574036 | 0.85 | FABP3 (0.67) | FABP3FABP4FABP5CDC25BMEN1 | |
| SCHEMBL2437912 | 0.85 | FABP3 (0.67) | FABP3FABP4FABP5CDC25BMEN1 | |
| SCHEMBL19874579 | 0.83 | FABP3 (0.45) | FABP3FABP4FABP5CDC25BMEN1 | |
| SCHEMBL15605284 | 0.83 | FABP3 (0.64) | FABP3FABP4FABP5CDC25BMEN1 | |
| SCHEMBL2793972 | 0.82 | CDC25B (0.60) | FABP3FABP4FABP5CDC25BMEN1 | |
| SCHEMBL30353953 | 0.82 | CDC25B (0.60) | FABP3FABP4FABP5CDC25BMEN1 | |
| SCHEMBL26157545 | 0.82 | FABP3 (0.55) | FABP3FABP4FABP5CDC25BMEN1 | |
| SCHEMBL18655632 | 0.81 | CDC25B (0.51) | FABP3FABP4FABP5CDC25BMEN1 | |
| SCHEMBL5370631 | 0.81 | FABP3 (0.62) | FABP3FABP4FABP5CDC25BMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180047913-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | JNC CORPORATION (JP) | 2018-02-15 | — | — | US | disclosed |
| US-9741950-B2 | Polycyclic aromatic compound | KYOTO UNIVERSITY (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160049600-A1 | POLYCYCLIC AROMATIC COMPOUND | SK MATERIALS JNC CO., LTD. (KR) | 2016-02-18 | — | — | US | disclosed |
| US-9166176-B2 | Polycyclic aromatic compound | KYOTO UNIVERSITY (JP) | 2015-10-20 | — | — | US | disclosed |
| US-20150097162-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | JNC CORPORATION (JP) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180047913-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | L1CAM, VDAC1, VDAC2 | FABP3 4613/4885FABP4 3245/4885FABP5 4344/4885 |
| US-20160049600-A1 | POLYCYCLIC AROMATIC COMPOUND | BICRA, PAH, SMARCC2 | FABP3 4760/4885FABP4 3757/4885FABP5 4477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.